Bortezomib - Takeda Oncology
At a glance
- Drug Originator Millennium Pharmaceuticals
- Drug Licenced by Janssen Pharmaceutical KK; Janssen-Cilag; Xian-Janssen
- Drug Class Amides; Anti-ischaemics; Antineoplastics; Antirheumatics; Boronic acids; Pyrazines; Small molecules; Vascular disorder therapies
- Mechanism of Action Apoptosis stimulants; NF-kappa B inhibitors; Proteasome inhibitors
- USA Patent Applicants TAKEDA PHARMS USA
- USA Patents 8
- NDAs 1
Table of Contents
Disclaimer